Current Trends in Regenerative Medicine: From Cell to Cell-Free Therapy

2016 ◽  
Vol 7 (1) ◽  
pp. 240-245 ◽  
Author(s):  
Marina O. Gomzikova ◽  
Albert A. Rizvanov
2019 ◽  
Vol 16 (4) ◽  
pp. 345-355 ◽  
Author(s):  
Jagadeesh Kumar Venkatesan ◽  
Ana Rey-Rico ◽  
Magali Cucchiarini

Author(s):  
Bilan O. A. ◽  
Brubaker I. O. ◽  
Marchenko-Tolsta K. S.

The review examines current trends in the development of biomedical nanotechnology, its application in various fields of medicine and prospects for further development. Among the main directions — monitoring and control of delivery, distribution and use of drugs; nanobiosensors; diagnostics of pathological states; theranostics; use of nanostructured materials in regenerative medicine; nanotoxicology; nanophytopharmacy; green synthesis; development of new nanobiotech devices and nanorobototics.


2019 ◽  
Vol 2019 ◽  
pp. 1-23 ◽  
Author(s):  
Greta Merkininkaitė ◽  
Darius Gailevičius ◽  
Simas Šakirzanovas ◽  
Linas Jonušauskas

Multiphoton 3D lithography is becoming a tool of choice in a wide variety of fields. Regenerative medicine is one of them. Its true 3D structuring capabilities beyond diffraction can be exploited to produce structures with diverse functionality. Furthermore, these objects can be produced from unique materials allowing expanded performance. Here, we review current trends in this research area. We pay particular attention to the interplay between the technology and materials used. Thus, we extensively discuss undergoing light-matter interactions and peculiarities of setups needed to induce it. Then, we continue with the most popular resins, photoinitiators, and general material functionalization, with emphasis on their potential usage in regenerative medicine. Furthermore, we provide extensive discussion of current advances in the field as well as prospects showing how the correct choice of the polymer can play a vital role in the structure’s functionality. Overall, this review highlights the interplay between the structure’s architecture and material choice when trying to achieve the maximum result in the field of regenerative medicine.


2019 ◽  
Vol 8 (5) ◽  
pp. 675
Author(s):  
Katarzyna Kornicka ◽  
Florian Geburek ◽  
Michael Röcken ◽  
Krzysztof Marycz

With this Editorial, we introduce the Special Issue “Adipose-Derived Stem Cells and Their Extracellular Microvesicles (ExMVs) for Tissue Engineering and Regenerative Medicine Applications” to the scientific community. In this issue, we focus on regenerative medicine, stem cells, and their clinical application.


2020 ◽  
Vol 20 (2) ◽  
pp. 82-88
Author(s):  
A. A. Chaplenko ◽  
M. D. Khorolsky ◽  
E. V. Melnikova ◽  
V. A. Merkulov

Cell therapy is a key tool of regenerative medicine, but until the beginning of the last decade, products based on viable human cells were used primarily to repair damaged tissues and organs. Currently, the field of application of biomedical cell products has expanded significantly, but researchers still show considerable interest in the use of human cells in regenerative medicine. The stage of development of cell products varies significantly depending on the type of tissue and pathology, and ranges from preclinical and pilot clinical trials to authorised drugs with a long history of use. On the one hand, this may be attributed to methodological differences in the production and use of cell products, and on the other, to specific aspects of differentiation of cell types used in regenerative medicine, primarily mesenchymal stem cells. The aim of this study was to analyse current trends in the use of cell therapy in regenerative medicine and prospects for using available technologies. The paper summarises the main achievements in the use of cell therapy for regeneration of skin, bone and cartilage, nervous and cardiovascular systems. The key mechanisms of cell therapy effect are determined, on the one hand, by the differentiation potential of multipotent cells, and on the other, by the complex (immunomodulating, angiogenic, proliferative) action of the proteome expressed by the administered cells. The paper describes viable cell-based products currently authorised for each indication, and analyses the level of their clinical use. It might be promising to use directed cell differentiation technologies, as well as induced pluripotent cells in regenerative medicine.


Author(s):  
Maryam Rahmati ◽  
Cristian Pablo Pennisi ◽  
Emma Budd ◽  
Ali Mobasheri ◽  
Masoud Mozafari

1991 ◽  
Vol 22 (2) ◽  
pp. 51-59 ◽  
Author(s):  
Kathy L. Coufal ◽  
Allen L. Steckelberg ◽  
Stanley F. Vasa

Administrators of programs for children with communicative disorders in 11 midwestern states were surveyed to assess trends in the training and utilization of paraprofessionals. Topics included: (a) current trends in employment, (b) paraprofessional training, (c) use of ASHA and state guidelines, and (d) district policies for supervision. Selection criteria, use of job descriptions, training programs, and supervision practices and policies were examined. Results indicate that paraprofessionals are used but that standards for training and supervision are not consistently applied across all programs. Program administrators report minimal training for supervising professionals.


Sign in / Sign up

Export Citation Format

Share Document